Trastuzumab Completed Phase 2 Trials for ERBB2 Gene Amplification / Neoplasms Metastasis / Stomach Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02004769Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer